glp-1 agonists gastrointestinal side effects constipation diarrhea Why Matters While on GLP-1/GIP-1 Medications Constipation is a common and sometimes underappreciated effect of and GIP-1 like semaglutide (Wegovy®) or tirzepatide (Zepbound®). Left untreated, it can lead GLP-1 Side Effects Compared: Which

Monomeric GLP-1/GIP/Glucagon Triagonism Corrects Obesity, Hepatosteatosis, and Dyslipidemia in Female Mice

P =0.01) and hospitalizations (HR, 0.88

Targeting the incretin/glucagon system with agonists Figure 1: Schematic representation of the effects of multi-agonists targeting the receptors for GLP-1/Glucagon, GLP-1/GIP and GLP-1/GIP/Glucagon [28] In Part I of our blog we reported on dual receptor agonists targeting the incretin/glucagon system to treat obesity and type 2 diabetes mellitus with high efficacy

Diabetes Type Specificity: While semaglutide is effective for type 2 diabetes, it is not suitable for type 1 diabetes management

Due to the nature of this analysis, no new primary data were generated